<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Exp Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin. Exp. Immunol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1365-2249</journal-id>
<journal-id journal-id-type="publisher-id">CEI</journal-id>
<journal-title-group>
<journal-title>Clinical and Experimental Immunology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0009-9104</issn>
<issn pub-type="epub">1365-2249</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28194750</article-id>
<article-id pub-id-type="pmc">5422860</article-id>
<article-id pub-id-type="doi">10.1111/cei.12943</article-id>
<article-id pub-id-type="publisher-id">CEI12943</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
<subj-group subj-group-type="heading">
<subject>Basic</subject>
<subj-group subj-group-type="heading">
<subject>Immune Regulation</subject>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Differential responses of human dendritic cells to metabolites from the oral/airway microbiome</article-title>
<alt-title alt-title-type="right-running-head">DC responses to oral bacterial metabolites</alt-title>
<alt-title alt-title-type="left-running-head">K. Whiteson <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="editor" id="cei12943-cr-0100">
<name>
<surname>Hodkinson</surname>
<given-names>John</given-names>
</name>
</contrib>
<contrib contrib-type="editor" id="cei12943-cr-0101">
<name>
<surname>Chapel</surname>
<given-names>Helen</given-names>
</name>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="author" id="cei12943-cr-0001">
<name>
<surname>Whiteson</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="cei12943-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="cei12943-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cei12943-cr-0002">
<name>
<surname>Agrawal</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="cei12943-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="cei12943-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cei12943-cr-0003">
<name>
<surname>Agrawal</surname>
<given-names>A.</given-names>
</name>
<address>
<email>Katrine@uci.edu</email>
<email>aagrawal@uci.edu</email>
</address>
<xref ref-type="aff" rid="cei12943-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cei12943-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Molecular Biology and Biochemistry</named-content>
<institution>University of California, Irvine</institution>
<named-content content-type="country-part">CA</named-content>
<country>USA</country>
</aff>
<aff id="cei12943-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Basic and Clinical Immunology, Department of Medicine</named-content>
<institution>University of California, Irvine</institution>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Correspondence: A. Agrawal, Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, Irvine, CA 92697, USA E‐mail: <email>Katrine@uci.edu</email><email>aagrawal@uci.edu</email></corresp>
<fn id="cei12943-note-0001">
<label>†</label>
<p>These authors contributed equally to this study.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<volume>188</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1111/cei.2017.188.issue-3</issue-id>
<issue-title content-type="special-issue-title">Immunology ‘in the clinic’ review series: focus on B cell immunodefi ciencies – challenges and considerations in diagnosis, treatment and management of patients</issue-title>
<fpage>371</fpage>
<lpage>379</lpage>
<history>
<date date-type="accepted">
<day>07</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 British Society for Immunology <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 British Society for Immunology</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CEI-188-371.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Summary</title>
<p>Small molecule metabolites that are produced or altered by host‐associated microbial communities are emerging as significant immune response modifiers. However, there is a key gap in our knowledge of how oral microbial metabolites affect the immune response. Here, we examined the effects of metabolites from five bacterial strains found commonly in the oral/airway microbial communities of humans. The five strains, each isolated from cystic fibrosis patient sputum, were <italic>Pseudomonas aeruginosa</italic> FLR01 non‐mucoid (P1) and FLR02 mucoid (P2) forms, <italic>Streptococcus pneumoniae</italic> (Sp), <italic>S. salivarius</italic> (Ss) and <italic>Rothia mucilaginosa</italic> (Rm). The effect of bacterial metabolites on dendritic cell (DC) activation, T cell priming and cytokine secretion was determined by exposing DCs to bacterial supernatants and individual metabolites of interest. Supernatants from P1 and P2 induced high levels of tumour necrosis factor (TNF)‐α, interleukin (IL)−12 and IL‐6 from DCs and primed T cells to secrete interferon (IFN)‐γ, IL‐22 compared to supernatants from Sp, Ss and Rm. Investigations into the composition of supernatants using gas chromatography–mass spectroscopy (GC‐MS) revealed signature metabolites for each of the strains. Supernatants from P1 and P2 contained high levels of putrescine and glucose, while Sp and Ss contained high levels of 2,3‐butanediol. The individual metabolites replicated the results of whole supernatants, although the magnitudes of their effects were reduced significantly. Altogether, our data demonstrate for the first time that the signature metabolites produced by different bacteria have different effects on DC functions. The identification of signature metabolites and their effects on the host immune system can provide mechanistic insights into diseases and may also be developed as biomarkers.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cei12943-kwd-0001">butanediol</kwd>
<kwd id="cei12943-kwd-0002">butanedione</kwd>
<kwd id="cei12943-kwd-0003">dendritic cells</kwd>
<kwd id="cei12943-kwd-0004">glucose</kwd>
<kwd id="cei12943-kwd-0005">oral microbiome</kwd>
<kwd id="cei12943-kwd-0006">putrescine</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Center for Advancing Translational Sciences
</funding-source>
<award-id>UL1 TR000153
</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>UC Davis West Coast Metabolomics Center pilot grant
</funding-source>
<award-id>DK097154
</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<page-count count="10"></page-count>
<word-count count="6275"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cei12943</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.9 mode:remove_FC converted:09.05.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>